This study investigates the effectiveness of using a preventative medication to improve long-term health outcomes for individuals experiencing an intracerebral haemorrhage, which is a type of stroke caused by bleeding inside the brain. The treatment being studied is levetiracetam, an antiseizure drug used to prevent seizures, which are sudden, uncontrolled electrical disturbances in the brain. The study aims to determine if giving this medication early can improve a person’s ability to perform daily activities following the bleeding event.

Participants in this trial will be assigned to receive either levetiracetam, which may be given as film-coated tablets for oral use or as a solution for infusion through a vein, or a placebo. This is a randomised study, meaning participants are placed into groups by chance, and it is double-blind, so neither the participants nor the researchers know which treatment is being administered during the process. The study will involve monitoring participants over several months to observe how the treatment affects their overall health and independence.